At ARVO Michael Siatkowski, MD, and Jody Summers, PhD, stopped to discuss the rising rates of myopia in children and if anti-inflammatory drugs could play a role in slowing progression.
R. Michael Siatkowski, MD, MBA
Advertisement
R. Michael Siatkowski, MD, MBA, serves as chief executive officer of DMEI, and he also holds the titles of Edward L. Gaylord Professor and Chair, as well as David Ross Boyd Professor in the Department of Ophthalmology at the University of Oklahoma College of Medicine in Oklahoma City.
Articles by R. Michael Siatkowski, MD, MBA
The CEO of Dean McGee Eye Institute reflects on the program’s milestones, global partnerships, and the future of patient-centered eye care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
2
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
3
The Residency Report: Cardiovascular risk scores as a window into ocular disease
4
Study links alcohol consumption to earlier advanced presbyopia in men
5